United StatesTaevas Global helps Personal Care & Beauty manufacturers navigate FDA regulations, customs clearance, and logistics strategy to move products into the United States market with confidence and compliance. From labeling requirements to port-of-entry procedu
Our six interconnected pillars give Personal Care & Beauty manufacturers a complete operational and regulatory foundation for importing into the United States market.
We map every applicable FDA requirement under the Federal Food, Drug, and Cosmetic Act and the Modernization of Cosmetics Regulation Act of 2022 (MoCRA) to your specific product portfolio. Our team identifies ingredient restrictions, prohibited substances, and mandatory safety substantiation obligations before your first shipment arrives. This proactive compliance review eliminates costly detentions and import alerts at the border.
Our four-step engagement process takes Personal Care & Beauty manufacturers from initial product assessment through full import readiness in a structured, timeline-driven workflow.
We begin with a structured intake of your product portfolio, existing formulations, ingredient lists, and current labeling. Our regulatory team screens each product against FDA requirements under MoCRA, the FD&C Act, and applicable CFR provisions to identify compliance gaps. This assessment produces a prioritized action list that forms the foundation of your import readiness plan.
The assessment covers ingredient safety screening against FDA prohibited and restricted substance lists, preliminary HTS classification review, labeling compliance gap analysis under 21 CFR Part 701, and identification of any products that may be classified as drugs rather than cosmetics under FDA definitions. Clients receive a written gap report with severity ratings and recommended remediation steps within 72 hours of intake completion.
The Modernization of Cosmetics Regulation Act of 2022 introduced the most significant overhaul of U.S. cosmetic regulation in over 80 years. All foreign manufacturers shipping cosmetics to the United States must now register their facilities and list their products with the FDA, with mandatory adverse event reporting obligations. Companies that fail to complete these requirements face import refusal and potential market exclusion.
FDA's Office of Regulatory Affairs conducts port-of-entry examinations of imported cosmetics with increasing frequency, particularly for products from markets with prior compliance issues. Import alerts such as Alert 53-09 for products containing prohibited color additives can result in automatic detention without physical examination for entire product lines. Proactive compliance documentation significantly reduces examination and detention risk.
U.S. consumer demand for clean, transparent formulations is reshaping retailer requirements and creating de facto ingredient standards that exceed FDA minimums. Major retailers including Sephora, Target, and Ulta Beauty maintain their own restricted substance lists that imported brands must satisfy to gain shelf placement. International brands must audit formulations against both regulatory and retail standards simultaneously.
The growth of direct-to-consumer e-commerce has created a parallel import pathway where small-quantity shipments enter as Section 321 de minimis entries, but FDA compliance obligations remain fully applicable. Brands selling through Amazon, TikTok Shop, or their own D2C channels still require compliant labels, MoCRA registrations, and safety substantiation files. Platform-specific compliance requirements add another layer of complexity for international entrants.
Every Taevas Global Imports & Shipments engagement for Personal Care & Beauty in the United States delivers eight structured workstreams covering compliance, logistics, market intelligence, and operational readiness.
A prioritized written assessment of your product portfolio against FDA MoCRA, FD&C Act, and 21 CFR requirements, with severity-rated findings and remediation recommendations.
Complete preparation of FDA facility registration submissions and product listing files including all required data elements for the responsible person and manufacturing facility.
Line-by-line review of ingredient lists against FDA prohibited and restricted substance lists, with corrected INCI lists and label specifications compliant with 21 CFR Part 701.
Confirmed HTS code assignments for all product categories with applicable duty rates, trade preference program eligibility, and a binding ruling recommendation where classification risk exists.
A recommended port-of-entry strategy with freight forwarder and customs broker briefing packages, FDA Prior Notice filing procedures, and examination response protocols.
A complete standard operating procedures manual for recurring shipments covering documentation requirements, filing timelines, broker instructions, and exception management escalation paths.
A structured overview of U.S. distribution channels relevant to your product categories, including mass, specialty, professional, and e-commerce channels with key retailer requirements.
A MoCRA compliance calendar with key filing and renewal deadlines, plus a regulatory monitoring protocol for tracking FDA guidance updates and import alert changes affecting your categories.
You manufacture Personal Care & Beauty products outside the United States and are ready to enter the world's largest beauty market but face an unfamiliar regulatory environment. MoCRA facility registration, FDA labeling requirements, and U.S. customs procedures are entirely new to your team. You need a structured, end-to-end import readiness program that gets your products on U.S. shelves compliantly and on schedule.
Connect with a Taevas Global specialist to build your Personal Care & Beauty import strategy for the United States market. From MoCRA compliance to first shipment clearance, we manage every step of the process.